HIV Vaccines

Tailor-Made AIDS Vaccines Urged

Published in AIDS Weekly, November 18th, 1996

Tailor the vaccine to fit the genes, suggests a leader of the U.S. HIV vaccine effort.

After reviewing the history and present status of HIV vaccine research, Duke University AIDS Center researcher Barton F. Haynes concluded that a successful AIDS vaccine will have to account for extensive genetic variability not only in the virus, but also in human populations.

The best way to do this, he argued, is to create HIV vaccines based on human leukocyte antigens (HLA).

Haynes's review-cum-manifesto appeared in the journal The Lancet ("HIV Vaccines: Where We Are and Where We Are Going," Lancet, 1996;348:933-37).

"In...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of AIDS Weekly

Source: AIDS Weekly (1996-11-18)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry